biomedicina slovenica


re="Cancer" : 508-607

  1. Kolarić K; Potrebica V; Stanovnik M
    Controlled phase III clinical study of 4-epidoxorubicin + 5-fluorouracil versus 5-fluoruracil alone in metastatic gastric and rectosigmoid cancer
    1985
  2. Furlan L; Šoba E
    Combined, multimodality treatment of advanced T3, T4 N0-3 squamous cell carcinoma of the oral cavity and oropharynx
    1985
  3. Fras P; Bebar S
    Cytophotometric characteristics of incurable carcinoma of the cervix uteri
    1985
  4. Červek J; Cerar O; Štabuc B; Plesničar S
    Aminoglutethimide in postmenopausal women with advanced breast carcinoma
    1985
  5. Auersperg M; Furlan L; Bergant D; Porenta O; Zorc R; Us-Krašovec M; Pompe F
    Intraarterial chemotherapy in advanced head and neck tumors
    1985
  6. Pirc B; Baltrusch HJF; Kralj M; Marolt F; Škrk J; Radonjić-Miholić V; Štante M; Stanovnik M; Vegelj-Pirc M; Kotnik V
    Neuro-psycho-immunological factors in the aertiology and prognosis of testicular tumors
    1985
  7. Pompe F; Auersperg M; Zorc R; Šurlan M
    Intraarterial chemotherapy in sarcomas
    1985
  8. Guinee VF; Guido JJ; Pfalzgraf KA; Giacco GG; Lagarde C; Durand M; Loewenberg B; Jereb B; Bretsky S; Meilof J; Hamersma EAM; Dische S; Anderson P
    The incidence of herpes zoster in patients with Hodgkin's disease
    1985
  9. Batista U; Sedmak B
    The influence of cytolysin from the sea anemone Condylactis aurantiaca on normal and malignant mammalian cell lines
    1985
  10. Serša G; Batista U; Krošl G; Rudolf Z
    Influence of soluble tumor products in vitro and in vivo
    1985
  11. Zorc R; Auersperg M; Us-Krašovec M; Vraspir-Porenta O
    Cell parameters - a basis for planning chemotherapying anaplastic giant cell carcinoma of the thyroid
    1985
  12. Auersperg M; Zorc R; Us-Krašovec M; Oblak M; Vodnik A; Porenta-Vraspir O; Petrič J; Novak J; Senčar M
    Individual treatment of recurrent sarcomas based on DNA measurements and cytomorphology
    1985
  13. Červek J; Cerar O; Štabuc B; Plesničar S
    Experience with aminoglutethimide in postmenopausal women with advanced breast carcinoma
    1985
  14. Rudolf Z; Serša G; Krošl G
    Maturation index as a nonspecific tumor marker in cancer patients
    1985
  15. Kolarić K; Potrebica V; Stanovnik M
    Controlled phase III clinical study of 4-epi-doxorubicin + 5-fluorouracil vs. 5-fluorouracil alone in metastatic gastric and rectosygmoid cancer
    1985
  16. Furlan L; Auersperg M; Šoba E
    Long-term results of synchronous chemotherapy (vinblastine, methotrexate, bleomycin) and radiotherapy in advanced T3, T4 NO-3 of the oral cavity and oropharynx
    1985
  17. Auersperg M; Us-Krašovec M; Porenta-Vraspir O; Vodnik A; Cerar O
    Combined theraphy of metastatic adult Wilms' tumor based on DNA measurements
    1985
  18. Auersperg M; Zorc R; Us-Krašovec M; Porenta-Vraspir O
    DNA measurements used for individual planning of chemotherapy in rare or chemoresistant tumors
    1985
  19. Lukič F; Zorc R; Pšeničnik M
    Damage of lymphocytes after irradiation as a possible cause of intestinal fibrosis. (Experiment on dogs
    1985
  20. Zwitter M; Kališnik M; Logonder-Mlinšek M; Sušec-Michieli M
    Radiosensitivity of rat follicular and parafollicular cells at various thyroid activity states
    1985
  21. Rudolf Z; Serša G; Krošl G
    Clinical significance of in vitro maturation defect of monocytes in cancer patients
    1984
  22. Kos L
    Surgical treatment of recurrent cervical cancer
    1983
  23. Rainer S
    Cervical carcinoma stage I. (Score for treatment)
    1983
  24. Čavič M; Rakar S; Kovačič J
    Analysis of treatment failures in stage I and stage II carcinoma of the cervix
    1983
  25. Kovačič J
    Surgical management and integrated therapies in invasive cervical cancer
    1983
  26. Pompe-Kirn V; Ravnihar B; Sok M; Primic-Žakelj M
    Second primary cancers among 5446 women treated for cancer or carcinoma in situ of the cervix uteri in Slovenia 1950-1969
    1983
  27. Ravnihar B; Adamič Š; Primic-Žakelj M; Stare J
    Breast cancer in reference to oral contraceptive use
    1984
  28. Pirc B; Baltrusch HJF; Kralj M; Marolt F; Radonjic-Miholič V; Stanovnik M; Vegelj-Pirc M
    Neuro-psycho-immunological factors in the aetiology and prognosis of testicular tumors
    1984
  29. Ravnihar B
    Breast cancer in reference to oral contraceptive use
    1983
  30. Pirc B
    Neuro-psycho-immunological factors in the aetiology and prognosis of testicular tumours
    1983
  31. Kolarič K; Potrebica V; Červek J
    Phase-II clinical trial of 4-epi-doxorubicin in metastatic solid tumors
    1983
  32. Ravnihar B
    Information support to evaluation of cancer control activities
    1983
  33. Ravnihar B; Adamič Š; Pirc B; Primic-Žakelj M; Stare J
    Breast cancer in reference to oral contraceptive use
    1983
  34. Ravnihar B
    Presentation of the use of Slovene cancer registry data
    1983
  35. Pompe-Kirn V; Primic-Žakelj M
    An epidemiologic analysis of early detection of cervical cancer in Slovenia
    1983
  36. Trichopoulos D; Hsieh C-C; Macmahon B; Lin T-M; Lowe CR; Mirra AP; Ravnihar B; Salber EJ; Valaoras VG; Yuasa S
    Age at any birth and breast cancer risk
    1983
  37. Benedik M; Orel J; Hrabar B; Ferluga D; Rott T
    Intrapleural Corynebacterium parvum as adjuvant therapy in operable bronchogenic non-small cell carcinoma: Preliminary report
    1982
  38. Fras AP; Poljanšek R
    Manual after-loading in cervical carcinoma
    1980
  39. Mavec P; Lukič F; Lenart IF
    Human breast lesions regarding the lymphoid infiltration
    1982
  40. Poljanšek RJ
    Differences between Heyman226RA and HeymanSimon 137Cs applications (dosimetry "in vitro")
    1982
  41. Macmahon B; Trichopoulos D; Brown J; Andersen AP; Cole P; Dewaard F; Kauraniemi T; Polychronopoulou A; Ravnihar B; Stormby N; Westlund K
    Age at menarche, urine estrogens and breast cancer risk
    1982
  42. Ravnihar B; Pompe-Kirn V
    Yugoslavia, Slovenia
    1982
  43. Ravnihar B
    Breast cancer in reference to oral contraceptive use
    1982
  44. Plesničar S; Kuszynski C; Patil KD
    Growth characteristics of pulmonary metastates from fibrosarcomas and malignant melanomas in mice
    1982
  45. Plesničar S; Rudolf Z
    Combined BCG and irradiation treatment of skin metastases originating from malignant melanoma
    1982
  46. Baltrusch HJF; Stangel W; Pirc B
    BIOBEHAVIORAL TUMOR MARKERS: THE NEED FOR PSYCHOLOGICAL SCREENING
    1982
  47. Eržen M; Rainer S; Kališnik M
    HISTOLOGICAL AND STEREOLOGICAL ANALYSIS OF MICROINVASIVE CARCINOMA OF THE UTERINE CERVIX
    1981
  48. Eckhardt S; Pleško I; Ravnihar B; Wrba H
    A REPORT OF AN ON-GOING JOINT COMPARATIVE STUDY OF CANCER INCIDENCE IN NEIGHBOURING REGIONS OF AUSTRIA, CZECHOSLOVAKIA,HUNGARY AND YUGOSLAVIA
    1982
  49. Macmahon B; Trichopoulos D; Brown J; Andersen AP; Aoki K; Cole P; Dewaard F; Kauraniemi T; Morgan RW; Purde M; Ravnihar B; Stormby N; Westlund K; Woo N-C
    AGEAT MENARCHE, PROBABILITY OF OVULATION AND BREAST CANCER RISK
    1982
  50. Plesničar S; Kuszynski C; Patil KD
    The growth of primary subcutaneous fibrosarcoma and its pulmonary mestastases in normal and athymic swiss mice
    1982
  51. Zwitter T; Soklič M; Bizjak-Schwarzbartl M; Majdič E; Lamovec J; Sever J
    METASTATIC CARCINOMA FROM AN OCCULT PRIMARY TUMOR
    1981
  52. Mavec P; Lenart IF
    DETECTION-EARLY DIAGNOSIS OF BREAST CANCER
    1980
  53. Rothman KJ; Macmahon B; Lin TM; Lowe CR; Mirra AP; Ravnihar B; Salber EJ; Trichopoulos D; Yuasa S
    MATERNAL AGE AND BIRTH RANK OF WOMAN WITH BREAST CANCER
    1980
  54. Kovačič J; Kožuh M; Andolšek L
    THE POSSIBLE INFLUENCE OF ORAL CONTRACEPTIVES ON THE INCIDENCE OF THE INVASIVE CARCINOMA, CARCINOMA IN SITU AND DYSPLASIA OF THE CERVIX
    1980
  55. Tavčar D; Stanley JR; Chapman P
    ENDODERMAL SINUS TUMOR OF THE PINEAL REGION
    1980
  56. Macmahon B; Andersen AP; Brown J; Cole P; Dewaard F; Kauraniemi T; Ravnihar B; Stormby N; Trichopoulos D; Westlund K
    URINE ESTROGEN PROFILES IN EUROPEAN COUNTRIES WITH HIGH OR LOW BREAST CANCER RATES
    1980
  57. Banič S
    Vitamin C acts as a cocarcinogen to methylcholanthrene in Guinea-pigs
    1981
  58. Mavec P; Lenart IF
    DETECTION-EARLY DIAGNOSIS OF BREAST CANCER
    1980
  59. Eržen M; Rainer S; Kališnik M
    HISTOLOGICAL AND STEREOLOGICAL ANALYSIS OF MICROINVASIVE CARCINOMA OF THE UTERINE CERVIX
    1980
  60. Kovačič J; Kožuh M; Andolšek L
    THE POSSIBLE INFLUENCE OF ORAL CONTRACEPTIVES ON THE INCIDENCE OF THE INVASIVE CARCINOMA, CARCINOMA IN SITU AND DYSPLASIA OF THE CERVIX
    1980
  61. Kambič V; Radšel Z; Gale N
    EVALUATION OF HISTOLOGIC CHANGES IN LARYNGEAL MUCOSA IN PREMALIGNANT GROWTH
    1980
  62. Plesničar S; Klanjšček G; Modic S; Rustia M
    Growth characteristics of pulmonary metastases from human sarcomas
    1979
  63. Plesničar S; Rudolf Z
    THE ENHANCING EFFECT OF IRRADIATION ON BCG TREATED MALIGNANT MELANOMA CUTANEOUS INFILTRATES
    1979
  64. Rudolf Z
    IMMUNOLOGIC TESTS IN PATIENTS WITH METASTATIC MALIGNANT MELANOMA - PROGNOSTIC VALUE
    1979
  65. Ludwig Group; Orel J; Benedik M; Hrabar B; Ferluga D; Rott T
    INTRAPLEURAL CORYNEBACTERIUM PARVUM AS ADJUVANT THERAPY IN OPERABLE (STAGE 1 AND 2) BRONCHIAL NON-SMALL CELL CARCINOMA; PRELIMINARY REPORT
    1979
  66. Ravnihar B; Seigel DG; Lindtner J
    AN EPIDEMIOLOGIC STUDY OF BREAST CANCER AND BENIGN BREAST NEOPLASIAS IN RELATION TO THE ORAL CONTRACEPTIVE AND ESTROGEN USE
    1979
  67. Plesničar S; Klanjšček G; Modic S
    THE GROWTH CHARACTERISTICS OF PULMONARY METASTASES IN HUMAN SARCOMAS
    1978
  68. Plesničar S; Klanjšček G; Modic S
    Actual volume doubling time values for pulmonary metastases from soft tissue sarcomas
    1978
  69. Ludwig Group; Orel J; Benedik M; Hrabar B
    SEARCH FOR THE POSSIBLE ROLE OF 'IMMUNOTHERAPY' IN OPERABLE BRONCHIAL NON-SMALL CELL CARCINOMA (STAGE 1 AND 2): A PHASE I STUDY WITH CORYNEBACTERIUM PARVUM INTRAPLEURALLY
    1978
  70. Morrison AS; Lowe CR; Macmahon B; Ravnihar B; Yuasa S
    INCIDENCE RISK FACTORS AND SURVIVAL IN BREAST CANCER: REPORT ON FIVE YEARS FOLLOW-UP OBSERVATION
    1977
  71. Jereb M; Us-Krašovec M
    TRANSTHORACIC NEEDLE BIOPSY OF MEDIASTINAL AND HILAR LESIONS
    1977
  72. Macmahon B; Ravnihar B; Yuasa S
    SOME INTERNATIONAL DIFFERENCES IN TREATMENT AND SURVIVAL IN BREAST CANCER
    1976
  73. Tefft M; Lattin PB; Jereb B; Cham W; Ghavimi F; Rosen G; Exelby P; Marcove R; Murphy ML; D'angio GJ
    ACUTE AND LATE EFFECTS ON NORMAL TISSUES FOLLOWING COMBINED CHEMO AND RADIOTHERAPY FOR CHILDHOOD RHABDOMYOSARCOMA AND EWING'S SARCOMA
    1976
  74. Lemerle J; Voute PA; Tournade MF; Delemarre JFM; Jereb B; Ahstrom L; Flamant R; Gerard-Marchant R
    PREOPERATIVE VERSUS POSTOPERATIVE RADIOTHERAPY, SINGLE VERSUS MULTIPLE COURSES OF ACTINOMYCIN D, IN THE TREATMENT OF WILMS' TUMOR
    1976
  75. Filipič Metka; Žegura Bojana; Fatur Tanja; Lah Tamara
    Antimutagenic effects of fermented milk product
    2001
  76. Fatur Tanja; Filipič Metka; Lah Tamara
    Co-mutagenic effects of cadmium and food mutagens IQ and B(a)P in HepG2 cells
    2001
  77. Gatta Gemma; Capocaccia Riccardo; Hakulinen Timo; Sant Milena; Verdecchia Arduino; De Angelis Gianni; Micheli Andrea; Berrino Franco; Pompe-Kirn V; et al ;
    Variations in survival for invasive cervical cancer among European women, 1978-89
    1999
  78. Serša G; Štabuc B; Čemažar M; Miklavčič D; Rudolf Z
    Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients
    2000
  79. Pavelić Jasminka; Lamovec Janez; Novak Janez; Gall-Trošelj Koraljka; Kapitanović Sanja; Pavelić Krešimir
    Collision tumour in the pelvic cavity: rectal leiomysarcoma and prostate adenocarcinoma
    2000
  80. Rotar-Pavlič Danica; Švab Igor; Keršič Mladen
    Perceived continuing medical education needs by Slovenian general practitioners
    1997
  81. Schweiger A; Staib A; Werle B; Krašovec M; Lah TT; Ebert W; Turk V; Kos J
    Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking
    2000
  82. Prechtl Anita; Thomssen Christoph; Meisner Christoph; Untch Michael; Weikel Werner; Wieland Gabriele; Lisboa Bjoern W; Hantschmann Peter; Beck Thomas; Čufer Tanja; et al ;
    Risk-adapted adjuvant chemotherapy in node-negative breast cancer patients guided by prognostic factors uPA and PAl-1: first interim-analysis of a randomized trial
    2000
  83. Bervar Aleš; Zajc Irena; Sever Nataša; Levičar Nataša; Filipič Metka; Kos Janko; Lah Tamara
    Expression of cysteine proteinases and their inhibitors levels in relation to invasiveness of human breast tumor cell lines
    2000
  84. Praprotnik S; Tomšič M
    Paraneoplastic arthritis
    2000
  85. Lah Tamara T; Čerček Miha; Blejec Andrej; Kos Janko; Gorodetsky Ella; Somers Robert; Daskal Ierachmiel
    Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators
    2000
  86. Fležar M; Kern I; Lavrenčak J; Žganec M; Us-Krašovec M
    Image analysis of buccal mucosa smears in lung cancer patients
    1998
  87. Bobnar A; Velepič M
    Safe handling of cytotoxic drugs in Slovenia
    1999
  88. Therasse P; Mauriac L; Welnicka M; Bruning P; Čufer T; Lichinitser R; Pluzanska A; Tomiak E; Koopmanschap M; Piccart M
    The added value of the combined evaluation of clinical efficacy, quality of life and cost-effectiveness in a randomized phase III study: results of an EORTC-NCIC-SAKK neoadjuvant trial in patients with locally advanced breast cancer (LABC)
    1999
  89. Malik I; Roth A; Ghilezan N; Čufer T; Lazarev A; Doval D; Ionescu-Goga S; Chernozemsky I; Quinaux E; Chirina N
    A phase II trial of taxotere (TXT) 100 or 75 mg/m2 as 2nd line chemotherapy (CT) in patients (PTS) with metastatic breast cancer (mbc) with stratification according to prognosis factors
    1999
  90. Uršič-Vrščaj Marjetka
    Hormone replacement therapy in women with a history of breast cancer
    1999
  91. Zwitter M
    Gemzar and oncovin: an effective regimen with low myelotoxicity in stage IV NSCLC
    1999
  92. Pompe-Kirn Vera; Primic-Žakelj Maja; Japelj Barbara
    Trends in lung cancer and smoking habits in the male population of Slovenia
    1999
  93. Bajetta E; Dirix LY; Fein LE; Jones SE; Červek J; Kaufmann M; Fowst C; Polli A; di Salle E; Massimini G
    Survival advantage of exemestane (EXE, aromasin) over megestrol acetate (MA) in postmenopausal women with advanced breast cancer (ABC) refractory to tamoxifen (TAM): results of a phase III randomized double-blind study
    1999
  94. Uršič H; Šalehar A
    Use of alginate dressings in the care of chronic wound
    1999
  95. Bešić N; Auersperg M; Us-Krašovec M; Golouh R; Brecelj E
    Primary treatment and survival in anaplastic thyroid carcinoma
    1999
  96. Novaković Srdjan; Ihan Alojz; Jezeršek Barbara
    Effectiveness of a simply designed tumor vaccine in prevention of malignant melanoma development
    1999
  97. Levičar N; Blejec A; Kos J; Golouh R; Vrhovec I; Frkovič-Gracio S; Lah TT
    Prognostic impact of serine and cysteine proteinases and their inhibitors in breast carcinoma
    1999
  98. Bonnefoi H; Biganzoli L; Čufer T; Hamilton A; Mauriac L; Van Hoorebeeck I; Piccart M
    A feasibility study of epirubicin (E) in combination with cyclophosphamide (C) and infusional 5-fluorouracil (F-infu)(CEF-infu) as primary treatment of large operable (LO) or locally advanced/inflammatory (LA/I) breast cancer (BC)
    1999
  99. Primic-Žakelj Maja
    The association of Slovenian cancer societies
    1999
  100. Alexander FE; Boyle P; Carli P-M; Coebergh JW; Ekbom A; Levi F; McKinney PA; McWhirter W; Michaelis J; Pompe-Kirn V
    Population density and childhood leukemia: results of the EUROCLUS study
    1999

   1 8 108 208 308 408 508 608 708  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics